The efficacy of new 2,5-dihydroxybenzyl derivatives against Trypanosoma cruzi, Leishmania infantum and Leishmania braziliensis. 2019

Miriam Rolón, and Alejandro Peixoto de Abreu Lima, and Cathia Coronel, and Maria Celeste Vega, and Enrique Pandolfi, and Antonieta Rojas de Arias
Centro para el Desarrollo de la Investigación Científica (CEDIC) (Diaz Gil Medicina laboratorial/FMB), Asunción, Paraguay. rolonmiriam@gmail.com.

Chagas disease and Leishmaniasis are among the most important parasitic diseases. They are considered to be within the most relevant group of neglected tropical diseases and have been included as priorities for searching new drugs due to their several treatment limitations. These parasitic diseases caused by flagellated protozoans affect more than 20 million people predominantly in developing countries. In this study, we prepared a series of 2-substituted 1,4-benzenediols by an efficient, green, and lithium salt-free synthesis in water/ethanol as solvent to test their anti-parasitic activity. All 36 phenolic derivatives were evaluated in vitro for their activity against T. cruzi epimastigotes, L. infantum, and L. braziliensis promastigotes, as well as their cytotoxicity on macrophage and fibroblast cell lines. Based on the results obtained, the compounds that presented a methyl, trifluoromethyl or bromo group at the para-position of the second benzene ring were found the most active analogs, with higher selective index values on the three parasites assayed. This evidence suggests that the anti-parasitic activity observed in these analogs is affected by the size of the group at the 4-position of the second ring, but not related with electronic factors.This study identified hit compounds with the potential to target several kinetoplastid parasites.

UI MeSH Term Description Entries
D007892 Leishmania braziliensis A parasitic hemoflagellate of the subgenus Leishmania viannia that infects man and animals. It causes cutaneous (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), and mucocutaneous leishmaniasis (LEISHMANIASIS, MUCOCUTANEOUS) depending on the subspecies of this organism. The sandfly, Lutzomyia, is the vector. The Leishmania braziliensis complex includes the subspecies braziliensis and peruviana. Uta, a form of cutaneous leishmaniasis in the New World, is caused by the subspecies peruviana. Leishmania (Viannia) braziliensis,Leishmania braziliensis braziliensis,Leishmania (Viannia) brasiliensis,Leishmania brasiliensis,Leishmania brasiliensis brasiliensis,Leishmania brasiliensis peruviana,Leishmania braziliensis peruviana,Leishmania viannia brasiliensis,Leishmania viannia braziliensis
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006873 Hydroquinones Derivatives of hydroquinone (1,4-dihydrobenzene) made by reduction of BENZOQUINONES. Quinol,p-Dihydroxybenzenes,para-Dihydroxybenzenes,Quinols,p Dihydroxybenzenes,para Dihydroxybenzenes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000981 Antiprotozoal Agents Substances that are destructive to protozoans. Schizonticides,Agents, Antiprotozoal
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Miriam Rolón, and Alejandro Peixoto de Abreu Lima, and Cathia Coronel, and Maria Celeste Vega, and Enrique Pandolfi, and Antonieta Rojas de Arias
October 2017, European journal of medicinal chemistry,
Miriam Rolón, and Alejandro Peixoto de Abreu Lima, and Cathia Coronel, and Maria Celeste Vega, and Enrique Pandolfi, and Antonieta Rojas de Arias
May 2012, Memorias do Instituto Oswaldo Cruz,
Miriam Rolón, and Alejandro Peixoto de Abreu Lima, and Cathia Coronel, and Maria Celeste Vega, and Enrique Pandolfi, and Antonieta Rojas de Arias
December 2009, Biochemical and biophysical research communications,
Miriam Rolón, and Alejandro Peixoto de Abreu Lima, and Cathia Coronel, and Maria Celeste Vega, and Enrique Pandolfi, and Antonieta Rojas de Arias
March 2022, Archiv der Pharmazie,
Miriam Rolón, and Alejandro Peixoto de Abreu Lima, and Cathia Coronel, and Maria Celeste Vega, and Enrique Pandolfi, and Antonieta Rojas de Arias
November 2017, Chemical biology & drug design,
Miriam Rolón, and Alejandro Peixoto de Abreu Lima, and Cathia Coronel, and Maria Celeste Vega, and Enrique Pandolfi, and Antonieta Rojas de Arias
March 2019, Molecules (Basel, Switzerland),
Miriam Rolón, and Alejandro Peixoto de Abreu Lima, and Cathia Coronel, and Maria Celeste Vega, and Enrique Pandolfi, and Antonieta Rojas de Arias
June 2016, Acta tropica,
Miriam Rolón, and Alejandro Peixoto de Abreu Lima, and Cathia Coronel, and Maria Celeste Vega, and Enrique Pandolfi, and Antonieta Rojas de Arias
May 2024, Bioorganic & medicinal chemistry,
Miriam Rolón, and Alejandro Peixoto de Abreu Lima, and Cathia Coronel, and Maria Celeste Vega, and Enrique Pandolfi, and Antonieta Rojas de Arias
July 2020, Parasitology research,
Miriam Rolón, and Alejandro Peixoto de Abreu Lima, and Cathia Coronel, and Maria Celeste Vega, and Enrique Pandolfi, and Antonieta Rojas de Arias
June 2022, Pathogens (Basel, Switzerland),
Copied contents to your clipboard!